Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Organigram Global ( (TSE:OGI) ) just unveiled an update.
Organigram Global has called an annual general and special meeting of shareholders for March 30, 2026 in Toronto, where investors will vote on the proposed indirect acquisition of all remaining shares of Berlin-based Sanity Group GmbH. The deal follows a February 18, 2026 share purchase agreement and is being financed through new senior secured credit facilities from ATB Financial and a sizeable equity private placement with British American Tobacco’s subsidiary.
The proposed transaction would give Organigram full control of Sanity Group, a fast-growing German and European cannabis operator whose revenues climbed from €9 million in 2023 to €60 million in 2025 and whose gross margins improved from 15% to 47% over the same period. Management argues the acquisition will be financially accretive, create a vertically integrated European hub anchored in Germany’s €2 billion medical cannabis market, extend the company’s retail and pilot-project presence in Switzerland and other countries, and broaden the reach of Organigram’s brands and IP across key European jurisdictions.
The most recent analyst rating on (TSE:OGI) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Organigram Global stock, see the TSE:OGI Stock Forecast page.
Spark’s Take on TSE:OGI Stock
According to Spark, TipRanks’ AI Analyst, TSE:OGI is a Neutral.
The score is held back primarily by weak operating profitability and negative cash flow despite revenue growth, reinforced by bearish technicals (below key moving averages and negative MACD). A low-leverage balance sheet and a moderate P/E provide partial support but are not enough to offset the core earnings and cash-flow risks.
To see Spark’s full report on TSE:OGI stock, click here.
More about Organigram Global
Organigram Global Inc. is a Canadian cannabis company headquartered in Toronto, with an established production and commercialization platform in its home market. The group focuses on branded cannabis products and is pursuing international expansion, targeting fast‑growing, federally regulated markets, particularly in Europe, to build a scalable global footprint.
YTD Price Performance: -12.99%
Average Trading Volume: 372,691
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$271.6M
Find detailed analytics on OGI stock on TipRanks’ Stock Analysis page.